Hematology NewsApixaban outmatches rivaroxaban in patients with AFib and valvular heart diseaseOctober 18, 2022ThrombosisPreventive Care
Hematology NewsNew deep dive into Paxlovid interactions with CVD medsOctober 17, 2022COVID-19 UpdatesThrombosis
Hematology NewsNew ESC guidelines for cutting CV risk in noncardiac surgerySeptember 15, 2022Preventive CareThrombosis
Hematology NewsRivaroxaban outmatched by VKAs for AFib in rheumatic heart diseaseAugust 28, 2022ThrombosisMixed Topics
Hematology TimesAXIOMATIC-SSP: Cautious optimism on factor XI inhibitor in strokeAugust 28, 2022Thrombosis
Hematology NewsLow-dose edoxaban curbs stroke risk in elderly with AF, despite frailtyAugust 25, 2022Thrombosis
Hematology NewsUpdates on treatment/prevention of VTE in cancer patientsAugust 9, 2022ThrombosisPreventive CareCOVID-19 Updates
Hematology NewsLong COVID doubles risk of some serious outcomes in children, teensAugust 5, 2022Long COVIDCOVID-19 UpdatesPediatricsThrombosis
Hematology NewsSCAI issues guidelines for PFO management, makes case for expansionMay 20, 2022Thrombosis
Hematology NewsUpdated AHA/ASA guideline changes care for spontaneous intracerebral hemorrhageMay 19, 2022Thrombosis
Oncology PracticeCancer patients unaware of their increased thrombosis riskMay 19, 2022Patient & Survivor CareThrombosis
Hematology NewsStroke in the young: Cancer in disguise?May 17, 2022ThrombosisMixed TopicsGastrointestinal Cancer
Hematology NewsFDA limits use of J&J COVID vaccine over blood clot riskMay 9, 2022ThrombosisCOVID-19 Updates
